The key goal was To judge the efficacy on the vaccine versus placebo in reducing cocaine use. Secondary goals integrated confirming vaccine immunogenicity as a result of IgG anti-cocaine antibody levels and assessing the security and tolerability of vaccination via a 20 7 days review and at 24 7 days https://ovinit539gow5.azzablog.com/profile